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A cDNA of rat brain encoding the GABA, receptor Q., subunit has been cloned. Recombinant receptors composed of ct.,, Bz and yz subunits bind 
with high affinity the GABA agonist [ZH]muscimol and the benzodiazepine ‘alcohol antagonist’ [‘H]Ro 15-4513. but fail to bind benzodiazepine 
agonists. The CL~ subunit is expressed mainly in the thalamus. as assessed by in situ hybridization histochemistry. and may participate 1.1 a major 
population of thalamic GABA, receptors. The uJ mRNA is found at lower levels in cortex and caudate putamen, and is rare in cerebellum. 
GABA,: Benzodiazepine receptor; In situ hybridization: Thalamus; CL Subunit heterogeneity 
1. INTRODUCTION 
GABA* receptors mediate the fast synaptic inhibi- 
tory effects of the neurotransmitter GABA in brain. 
This receptor is a ligand-gated anion channel. and is the 
target of action for a variety of psychoactive com- 
pounds such as barbiturates, benzodiazepines, neuro- 
steroids and ethanol [1,2]. The GABAA receptor is as- 
sumed to be a pentameric structure composed of sub- 
units belonging to subunit classes a. /?. y, 6 and p [3.4]. 
So far, in the rodent fiva o! subunit types have been 
identified by cDNA screening. These are a, [5]. ~1~ [6], 
CI~ [7], ~1~ [5,7,Sj and CQ, i9. IO]. The subunit termed by us 
and others as ~1, [7,8] has also been termed as ~1~ [5]. A 
cDN A encoding a bovine 01~ subunit has been isolated 
although not pharmacologically characterized [ 1 I]. with 
the existence of a rat cl,, homologue remaining uncertain 
[ll]. The 01 subunits are a major factor determining 
pharmacological diversity in GABAA receptors, with 
different a subunits combining with a/3/y pair to exhibit 
a broad spectrum of pharmacology [3,8,9,12]. Since it 
is important to analyze the whole repertoire of GABA* 
receptor subunits in an accessible experimental model, 
we have cloned the rat CL~ subunit mRNA and studied 
the sites of its expression in the rodent brain. At the 
same time, we present the first pharmacological 
characterization of this subunit. 
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2. MATERIALS AND METHODS 
2.1. holotion of cDNA clonc~s 
A rat brain cDNA library constructed in A-zap (Stratagene) was 
screened using a Y:P-labelled DNA fragment of the bovine 0~~ cDNA 
[I I]. A cloned 3.6 kb cDNA was identified and subcloned by in vivo 
excision into Bluescript plasmid. From this cDNA. a 0.6 kb A’ptrl 
fragment. a 0.6 kb EcoRI fragment and a 2.2 kb E~oRIIX!UYI fragment 
were subcloned into M 13 vectors [ 131 and sequenced [141. The 2.2 kb 
EcoRIIXbnl fragment was sequenced with the aid of two internal 
primers, 5-‘TTCTCAAGTITGCTTCTGG-3’ (ra,.,). and S-TGTG- 
TACCACATATCCCT-3’ (ru,& A 2.9 kb XLJRI fragment containing 
the entire coding sequence as well as 0.2 kb of S-untranslated and 0.8 
kb of 3’-untranslated regions was used to construct a eukaryotic ex- 
pression vector [8] for the rat uJ subunit. 
Expression veciori for a,. & and y: cDNAs were transfected in 
triple combinations into human embryonic kidney (293) cells (ATCC 
# CRL 1573) asdescribed previously [I’]. Bindingstudies werecarried 
out identically to previous protocols [8.9.12]. 
A 45 base antisense oligonucleotide (5’~CAAGTCGCCAGGCA- 
CAGGACGTGCAGGAGGGCGAGGCTGACCCCG-3’) was con- 
structed to a unique part of the CL, subunit mRNA. complementary to 
amino acids 15 to 30 of the signal peptide. A 45 basea, oligonucleotide 
was complemcnrary to the region encoding subunit residues 342-356 
[S]. These probes were enzymatically labelled with terminal transfer- 
ase. at a 30:1 molar ratio of [“S]dATP (1200 Wmmol) to oligonucle- 
otide. In situ hybridization was performed as described previously 
[15]. In brief. 14 pm cryostat sections were hybridized with 3’ end- 
labelled oligonucleotides in 50% formamide x SSCllO% dextran 
sulphate overnight at 42°C. Sections were washed 10 a final stringency 
of I x SSC at 6OOC. dehydrated and exposed to XAR-5 (Kodak) film. 
Competition experiments with an excess (50-fold) of unlabelled probe 
resulted in blank autoradiographs. 
3. RESULTS AND DISCUSSION 
Screening of a rat forebrain cDNA library with a 
bovine a4cDNA probe at high stringency resulted in the 
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Fig. I. Nuclcotidc and deduced amino acid sequence of the rat 
GABA,, receptor 01~ subunit. The arrow marks potential cleavage site 
of signal peptide; N. potential N-glycosylution sites; filled circles. 
potential protein kinasc C phosphorylation sites; open circles, potcn- 
Lial CAMP dependent protein kinasc phosphorylation site; transmem- 
branc domains are boxed. The dotted line indicates the I5 residue 
disuliide-bonded loop region. 
isolation of a cDNA with an open reading frame of 1656 
nucleotides encoding a protein of 552 amino acid resi- 
dues, including a predicted signal sequence of 19 amino 
acids (Fig. 1). The deduced amino acid sequence reveal- 
ed an 88% sequence identity with the bovine a4 subunit 
iSI. Like its bovine counterpart, the rat a3 polypeptide 
is predicted to contain a large cytoplasmic portion, ma- 
king a4 the largest GABA, receptor subunit to date 
(MW of unglycosylated mature polypeptide, 65 kDa). 
The putative cytoplasmic sequence contains two poten- 
tial sites for CAMP dependent phosphorylation and one 
for protein kinase C phosphorylation (Fig. 1). 
The pharmacology of the cl4 subunit was examined by 
co-expression withBz and yr subunits in cultured mam- 
malian 293 cells (Table I). The oQ,y? receptors exhibit- 
ed high-affinity binding sites for [3H]muscimo1 and high 
affinity sites for the benzodiazepine [3H]Rol 54513. 
However, the latter compount was only poorly dis- 
placed by the benzodiazepine agonist diazepam (10 
,uM). This binding profile is very similar to that ob- 
served for a,&yz receptors and very different from 
~18~~~ receptors, suggesting that the b, and a6 subunits 
may share functional properties. 
Regarding the sites of a4 subunit gene expression, the 
01, mRNA is very abundant in most thalamic nuclei 
examined (for example, ventral posterior nucleus, me- 
dial geniculate nucleus) but is almost entirely absent 
from hypothalamus (Fig. 2). In thalamus, and also in 
hippocampus, the distribution of ~1, and ~1~ mRNAs are 
well matched. However, their respective distributions in 
other brain regions suggest that the enclosed subunits 
occur in distinct receptor complexes. The cy, and a, 
mRNAs have reciprocal distributions in the basal gan- 
glia. The ~1~ mRNA is more abundant than aI in the 
caudate nucleus. In contrast, ol mRNA predominates 
in globus pallidus. In addition, a, mRNA is very abun- 
dant in medial septum, an area where ~1~ mRNA is 
absent. The a4 transcript is absent or very rare in cere- 
bellum and colliculi, both regions containing high a- 
mounts of Q, mRNA. 
These data suggest that the 01~ subunit participates in 
the formation of a previously uncharacterized native 
GABA, receptor which would fail to bind BZ agonists. 
Such a receptor subtype would be found mainly in fore- 
brainithalamic structures. Additionally, since the cy, and 
~1, polypeptides exhibit very similar functional proper- 
ties, they can be grouped together in a subfamily of the 
cc subunits. 
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